Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.

To thwart pathogens, researchers in the epidemiology field of infectious disease (ID) prediction are continuously trying to forecast when, where, and how an ID event will occur.

A PNNL team developed and used a model framework to understand the performance and structural reliability of a state-of-the-art solid oxide electrolysis cell design.

Silicone wristbands could be more convenient option for collecting exposure data.

Tailoring hydrogen-based energy storage solutions to specific real-world applications.

PNNL computational neuroscientist Rogene Eichler West honored with the International Society for Neuroregulation & Research Joseph and Ann Marie Horvat Distinguished Service Award.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

Interns dive into important research that addresses national needs.

PNNL Senior Scientist Jamie Holladay has been named a Distinguished Inventor of Battelle.

TransMED analyzes patient data from similar diseases across multiple sources to understand COVID-19 patient outcome risk factors.

PNNL researchers studying materials to enable safe, cost-effective hydrogen storage.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

PNNL Hydrogen Safety Panel supports a fundamental hydrogen safety credential deployed through the Center for Hydrogen Safety.

The Department of Homeland Security Science and Technology Virtual First Responder Capitol Hill Showcase highlighted PNNL work in fentanyl detection standards and database libraries.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

The paper was recognized by the Society of Toxicology’s Medical Device and Combination Product Specialty Section.

Morris Bullock has led PNNL's pursuit of the efficient conversion of electrical energy and chemical bonds through control of electron and proton transfers.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Materials scientist Arun Devaraj is committed to improving the quality and performance of metals with a big assist from atom probe tomography.